Journal Article

Optimal dose of losartan for renoprotection in diabetic nephropathy

Steen Andersen, Peter Rossing, Tina R. Juhl, Jaap Deinum and Hans‐Henrik Parving

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 17, issue 8, pages 1413-1418
Published in print August 2002 | ISSN: 0931-0509
Published online August 2002 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/17.8.1413
Optimal dose of losartan for renoprotection in diabetic nephropathy

Show Summary Details

Preview

Background. Angiotensin II subtype‐1 receptor antagonists represent a valuable new class of drugs in the treatment of diabetic nephropathy. The aim of our study was to evaluate the optimal dose of losartan for renoprotection and blood pressure reduction in diabetic nephropathy.

Methods. Fifty consecutive hypertensive type 1 diabetic patients with diabetic nephropathy received increasing doses of losartan, 50, 100, and 150 mg once daily in three periods each lasting 2 months. At baseline and at the end of each treatment period, albuminuria, 24‐h blood pressure (TM2420 A&D), and glomerular filtration rate (GFR) ([51Cr]EDTA plasma clearance) were determined.

Results. Baseline values of albuminuria (geometric mean (95% CI)) and GFR (means±SEM) were 1138 (904–1432) mg/24 h and 91±3 ml/min/1.73 m2, respectively. The blood pressure at baseline was 155/81±3/2 mmHg. All doses of losartan reduced albuminuria and blood pressure. Albuminuria was reduced by 30% (95% CI (15–41)) on losartan 50 mg, 48% (35–57) by losartan 100 mg, and 44% (32–56) by losartan 150 mg (all P values <0.01 vs baseline). Losartan 100 mg daily was significantly more effective than 50 mg daily in reducing albuminuria (P<0.01) without differences between the two high doses. Losartan 50, 100, and 150 mg daily decreased systolic/diastolic blood pressures by 7/4, 12/6, and 10/5 mmHg, respectively (all P<0.05). Losartan 100 mg daily was more effective than 50 mg daily in reducing systolic, diastolic, and mean arterial blood pressure (P=0.05), without differences between the high doses. Treatment with losartan 100 and 150 mg lowered GFR by 4 ml/min/1.73 m2 (P<0.05).

Conclusion. Our study suggests that the optimal dose of losartan is 100 mg daily for renoprotection and blood pressure reduction in type 1 diabetic patients with diabetic nephropathy.

Keywords: albuminuria; angiotensin II; diabetes; hypertension; losartan; nephropathy

Journal Article.  3935 words. 

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.